Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Inflammation-Schizophrenia: A Bidirectional Causal Association Mediated by Cytokines Publisher



Shamabadi A1, 2 ; Akhondzadeh S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Avicenna Journal of Medical Biotechnology Published:2023


Abstract

[No abstract available]
Related Docs
1. Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial, International Journal of Neuropsychopharmacology (2020)
2. Efficacy and Safety of Adjunctive Therapy With Fingolimod in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Schizophrenia Research (2023)
3. Cytokine Alterations in Schizophrenia: An Updated Review, Frontiers in Psychiatry (2019)
4. Cilostazol Adjunctive Therapy in Treatment of Negative Symptoms in Chronic Schizophrenia: Randomized, Double-Blind, Placebo-Controlled Study, Human Psychopharmacology (2017)
5. Toward Personalized Psychiatry: Integrating Pharmacogenetics Into Psychiatry, Journal of Iranian Medical Council (2023)
6. Adjuvant Palmitoylethanolamide Therapy With Risperidone Improves Negative Symptoms in Patients With Schizophrenia: A Randomized, Double-Blinded, Placebo-Controlled Trial, Psychiatry Research (2022)
7. Interdisciplinary Collaboration Between Bench and Bedside in the Covid-19 Pandemic, Avicenna Journal of Medical Biotechnology (2023)
8. Integrating Psychiatry and Medical Biotechnology As a Way to Achieve Scientific, Precision, and Personalized Psychiatry, Avicenna Journal of Medical Biotechnology (2021)
Experts (# of related papers)
View all Related Experts
Shahin Akhondzadeh Basti (7)
Farzin Rezaei (2)